In my latest for @statnews, a custom therapy made for a young girl with a rare genetic disorder hints at the feasibility of individualized medicines.
Thanks @timyu@BradMargus@stopbatten@ToshifumiYokota for speaking with me on the topic!
https://t.co/ngx8Ol7UKL
1/ Spatial Genomics is very excited to announce the launch of Gene Positioning System (GenePS), the first confocal end-to-end solution for spatial multiomics assays based on seqFISH technology! Please retweet! Check out more info at https://t.co/c10xiqdJ2h
#GenePS#seqFISH
An #ASO therapy reduced tau levels in patients with #AlzheimersDisease in a phase 1b trial, but whether this translates to clinical improvement remains to be seen.
Read the News and Views from Peter Ljubenkov & Gil Rabinovici
@RabLab_UCSF @UCSFMedicine
https://t.co/8pyTKou8gK
Case report of an individual heterozygous for a rare RELN-COLBOS variant that confers resilience, via a gain-of-function mechanism, to #Alzheimer’s disease. https://t.co/HUgwzRXGP9 @ytquiroz @DrJoeArboleda@diegosflab
Excited to release our preprint presenting two-layer DNA seqFISH+ to map over 100,000 genomic loci, beyond the 3660 loci we have previously demonstrated, and revealing subnuclear compartments in neurons and glial cells in the cerebellum.
PD is the second most common neurodegenerative disease after AD. It affects many, including those who research it. Thanks Dr. Greenamyre for sharing your story and contributing to our understanding of the genetic and environmental factors driving PD
https://t.co/gZ5v2GkObx